Abstract
Last year, at the height of the Ebola outbreak, Sina Bavari and Travis Warren found their labs at the U.S. Army Medical Research Institute of Infectious Diseases ( USAMRIID) flooded with compounds for testing against the Ebola virus. Well-meaning drug companies hoping to help stem the crisis were offering anything that might have activity against Ebola to the government lab, which is one of only a handful of places in the country with a containment facility for screening molecules against the deadly virus. Bavari and Warren were happy for the help but also overwhelmed as well as uncertain whether anything they were getting would actually work. Most of the compounds were developed for other diseases. Bavari, who is chief scientific officer of USAMRIID, compared the screening effort to trying to catch apples by holding a basket under a peach tree. Fortunately, at least one apple seems to have fallen. In ...
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
